{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T08:00:13Z","timestamp":1769241613609,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.taap.2018.01.019","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T13:02:51Z","timestamp":1517490171000},"page":"69-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Different effects of ursodeoxycholic acid on intrahepatic cholestasis in acute and recovery stages induced by alpha-naphthylisothiocyanate in mice"],"prefix":"10.1016","volume":"342","author":[{"given":"Linlin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huizong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaofeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.taap.2018.01.019_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchromb.2008.08.018","article-title":"Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS\/MS","volume":"873","author":"Alnouti","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"6","key":"10.1016\/j.taap.2018.01.019_bb0015","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1053\/j.gastro.2015.08.031","article-title":"Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis","volume":"149","author":"Beuers","year":"2015","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.taap.2018.01.019_bb0020","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1177\/0192623316662360","article-title":"Acute alpha-naphthylisothiocyanate induced liver toxicity in germfree and conventional male rats","volume":"44","author":"Cullen","year":"2016","journal-title":"Toxicol. Pathol."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2018.01.019_bb0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/liv.13306","article-title":"Management of cholestatic disease in 2017","volume":"37","author":"de Vries","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.taap.2018.01.019_bb0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0300-483X(01)00459-0","article-title":"Role of MRP2 and GSH in intrahepatic cycling of toxins","volume":"167","author":"Dietrich","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2018.01.019_bb0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/gast.2001.25542","article-title":"Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver","volume":"121","author":"Fickert","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2018.01.019_bb0040","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jhep.2013.01.026","article-title":"Differential effects of norUDCA and UDCA in obstructive cholestasis in mice","volume":"58","author":"Fickert","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2018.01.019_bb0045","first-page":"1","article-title":"An intestinal microbiota\u2013farnesoid X receptor axis modulates metabolic disease","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2018.01.019_bb0050","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jpba.2011.03.035","article-title":"Simultaneous characterization of bile acids and their sulfate metabolites in mouse liver, plasma, bile, and urine using LC\u2013MS\/MS","volume":"55","author":"Huang","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.taap.2018.01.019_bb0055","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1365-2036.2011.04863.x","article-title":"High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis","volume":"34","author":"Imam","year":"2011","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.taap.2018.01.019_bb0060","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.28965","article-title":"The ascending pathophysiology of cholestatic liver disease","volume":"65","author":"Jansen","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2018.01.019_bb0065","first-page":"1","article-title":"Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis","volume":"00","author":"Joshi","year":"2016","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.taap.2018.01.019_bb0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/faat.1995.1074","article-title":"Biliary epithelial cell proliferation following alpha-naphthylisothiocyanate (ANIT) treatment: relationship to bile duct obstruction","volume":"26","author":"Kossor","year":"1995","journal-title":"Fundam. Appl. Toxicol."},{"issue":"3","key":"10.1016\/j.taap.2018.01.019_bb0075","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2018.01.019_bb0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.taap.2015.01.020","article-title":"Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis","volume":"283","author":"Meng","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2018.01.019_bb0085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/jhep.2002.34939","article-title":"Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CXP and preservation of BSEP activities","volume":"36","author":"Paolini","year":"2002","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.taap.2018.01.019_bb0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/CS20110184","article-title":"Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications","volume":"121","author":"Roma","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.taap.2018.01.019_bb0095","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1478-3231.2009.02048.x","article-title":"Focal liver necrosis appears early after partial hepatectomy and is dependent on T cells and antigen delivery from the gut","volume":"29","author":"Rudich","year":"2009","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.taap.2018.01.019_bb0100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.23631","article-title":"Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression","volume":"52","author":"Sinakos","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.taap.2018.01.019_bb0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/toxsci\/kfr177","article-title":"Dose-response of five bile acids on serum and liver bile acid concentrations and hepatotoxicty in mice","volume":"123","author":"Song","year":"2011","journal-title":"Toxico. Sic."},{"key":"10.1016\/j.taap.2018.01.019_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jep.2016.08.049","article-title":"Target profiling analyses of bile acids in the evaluation of hepatoprotective effect of gentiopicroside on ANIT-induced cholestatic liver injury in mice","volume":"194","author":"Tang","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2018.01.019_bb0115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tox.2017.05.012","article-title":"Glycyrrhizin and glycyrrhetinic acid inhibits alpha-naphthyl isothiocyanate-induced liver injury and bile acid cycle disruption","volume":"386","author":"Wang","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2018.01.019_bb0120","article-title":"Comprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodents","volume":"1-36","author":"Watanabe","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2018.01.019_bb0125","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1194\/jlr.M007641","article-title":"Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice","volume":"51","author":"Zhang","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.taap.2018.01.019_bb0130","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1478-3231.2011.02662.x","article-title":"Effect of bile duct ligation on bile acid composition in mouse serum and liver","volume":"32","author":"Zhang","year":"2012","journal-title":"Liver Int."},{"issue":"29","key":"10.1016\/j.taap.2018.01.019_bb0135","doi-asserted-by":"crossref","first-page":"26757","DOI":"10.18632\/oncotarget.5610","article-title":"A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis","volume":"6","author":"Zhu","year":"2015","journal-title":"Oncotarget"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18300267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18300267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T09:52:53Z","timestamp":1535104373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18300267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":26,"alternative-id":["S0041008X18300267"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.01.019","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different effects of ursodeoxycholic acid on intrahepatic cholestasis in acute and recovery stages induced by alpha-naphthylisothiocyanate in mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}